Contact:
Liven Qian(钱叶华)-Custom Peptide
Mobile: 13761298676(微信)
Email:cps037@chinapeptides.net
QQ:2880526724
ChinaPeptides Co., Ltd./强耀生物科技有限公司
04010014127
Angiotensin II, human
DRVYIHPF
Number of Residues: | 8 |
1-Letter Code: | DRVYIHPF |
3-Letter Code: | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe |
Molecular weight (Mr): | 1046.19 g/mol |
Isoelectric point: | 7.4 |
Net charge at pH 7.0: | 0.1 |
Average hydrophilicity: | -0.3 |
Ratio of hydrophilic residues / total number of residues: | 25 % |
Name | Angiotensin II, human |
Code | [4474-91-3] |
The alias | Angiotensin II, human |
Sequence (single letter abbreviation) | DRVYIHPF |
Sequence (three-letter abbreviation) | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH (trifluoroacetate salt) |
A basic description | "Anti-angiotensin II" peptide deduced from the antisense mRNA complementary to the human angiotensin II mRNA. The sequence of this octapeptide is 50% homologous to angiotensin II but functions as an antagonist of angiotensin II, causing uterine contractions and hypertensive responses in rats. |
solubility | |
The molecular weight | 1046.2 |
Chemical formula | C50H71N13O12 |
The purity | 80%,90%,95%,98%,99% |
Weight | 1mg,5mg,10mg,50mg,100mg,1g |
Storage conditions | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
Annotation | |
Documents | |
Figures | |
Reference | A.W.A. Hahn et al., J. Cardiovasc. Pharmacol., 22 (Suppl.5), S37 (1993) T. Inagami et al., Cardiovase. Drugs Ther., 2, 453 (1988) |
评论
发表评论